Mississippi Administrative Code › Title 30 - Professions and Occupations › Part 2640 - Rules Pertaining to Prescribing, Administering, and Dispensing Medication › Chapter 1 - Rules Pertaining to Prescribing, Administering and Dispensing of Medication › Rule 30-2640-1.7 - Use of Controlled Substances for Chronic (Non-Cancer/Non-Terminal)

Current through June 25, 2024
The following rules are not intended to supersede or exempt
				  licensees from the requirements heretofore stated in Rule
				  1.4
Maintenance of Records
				  and Inventories.
A.
				Definitions
For the purpose of Part 2640, Rule 1.7 only, the following
				  terms have the meanings indicated:
1.
				"
Chronic Pain
" is a pain state in which the cause of
				the pain cannot be removed or otherwise treated and which in the generally
				accepted course of medical practice, no relief or cure of the cause of the pain
				is possible or none has been found after reasonable efforts including, but not
				limited to, evaluation by the attending licensee and one or more licensee
				specializing in the treatment of the area, system, or organ of the body
				perceived as the source of the pain. Further, if a patient is receiving
				controlled substances for the treatment of pain for a prolonged period of time
				(more than three months), then they will be considered for the purposes of this
				regulation to have "de facto" chronic pain and subject to the same requirements
				of this regulation. "Terminal Disease Pain" should not be confused with
				"Chronic Pain."
2. "
Terminal Disease Pain
" is pain arising from a medical
				condition for which there is no possible cure and the patient is expected to
				live no more than six (6) months.
3. "
Acute Pain
" is
				the normal, predicted physiological response to an adverse chemical, thermal,
				or mechanical stimulus and is associated with surgery, trauma and acute
				illness. Acute pain is generally self-limited and is responsive to therapies,
				including controlled substances.
4. "
Addiction
" is a
				neurobehavioral syndrome with genetic and environmental influences that results
				in psychological dependence on the use of substances for their psychic effects
				and is characterized by compulsive use despite harm.
5. "
Physical
				Dependence
" is a physiological state of neuroadaptation to
				substance which is characterized by the emergence of a withdrawal syndrome if
				the use of the substance is stopped or decreased abruptly, or if an antagonist
				is administered. Withdrawal may be relieved by re-administration of the
				substance.
6. "
Substance Abuse
" is the use of any substance for
				non-therapeutic purposes; or use of medication for purposes other than those
				for which it is prescribed.
7. "
Tolerance
" is a physiological state resulting from
				regular use of a drug in which an increased dosage is needed to produce the
				same effect or a reduced effect is observed with a constant dose. Tolerance
				occurs to different degrees for various drug effects, including sedation,
				analgesia and constipation. Analgesic tolerance is the need to increase the
				dose of opioid to achieve the same level of analgesia.